Surprise finding could lead to new MS treatments

March 8, 2018 by Ross Neitz, University of Alberta
Biochemistry professor Marek Michalak is part of a research team that was surprised to discover unusually high levels of a protein called calnexin in brain tissue from people who had MS—a finding that could lead to new ways of treating the debilitating disease. Credit: University of Alberta

A surprise finding by medical scientists may lead to the development of a possible treatment for multiple sclerosis (MS).

While examining human brain tissues, researchers from the University of Alberta and McGill University unexpectedly found that the tissues from people who had MS contained an extremely high level of a protein named calnexin, compared with those who hadn't had MS.

The researchers then tested the susceptibility of mice lacking calnexin to the mouse model of human MS (experimental autoimmune encephalomyelitis), and were astonished to find that the mice lacking the protein were completely resistant to the disease.

The causes of MS are not well understood. Symptoms vary widely but often include cognitive impairment, dizziness, tremors and fatigue. These problems are caused by a type of called T cells that, after becoming activated, find their way into the brain and attack the protective covering—myelin—of neurons in the brain and spinal cord, causing inflammation and damage to the central nervous system.

"It turns out that calnexin is somehow involved in controlling the function of the blood-brain barrier," said Marek Michalak, a distinguished professor of biochemistry at the U of A. "This structure usually acts like a wall and restricts the passage of cells and substances from the blood into the brain. When there is too much calnexin, this wall gives angry T cells access to the , where they destroy myelin."

Canada has one of the highest rates of MS in the world, with an estimated one in 340 Canadians living with the disease. There are no known effective treatments.

"We think this exciting finding identifies calnexin as an important target for developing therapies for MS," said Luis Agellon, a professor at the McGill School of Human Nutrition. "Our challenge now is to tease out exactly how this protein works in the involved in making up the . If we knew exactly what calnexin does in this process, then we could find a way to manipulate its function to promote resistance for developing MS."

Explore further: Potential new approach to the treatment of multiple sclerosis

More information: Joanna Jung et al. Calnexin is necessary for T cell transmigration into the central nervous system, JCI Insight (2018). DOI: 10.1172/jci.insight.98410

Related Stories

Potential new approach to the treatment of multiple sclerosis

March 5, 2018
A prospective new method of treating patients with multiple sclerosis has been proposed by researchers of the Mainz University Medical Center working in cooperation with researchers of the University of Montreal. In model ...

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

ALS-linked protein's journey into nervous system cells more complex than we thought

February 28, 2018
University of Bath scientists have developed a better understanding of a key protein associated with brain diseases including ALS (motor neurone disease) and dementia by studying how it enters central nervous system cells.

Faults in the blood-brain barrier implicated in dementia

February 6, 2018
California based researchers have found that damage to cells known as pericytes, which surround small blood vessels in the brain, may trigger a chain of events that results in brain degeneration. The findings are published ...

Researchers report novel complementary effects of estrogen treatment in multiple sclerosis

December 28, 2017
A study by UCLA researchers reveals the cellular basis for how the hormone estrogen protects against damage to the central nervous system in people with multiple sclerosis (MS). The researchers found that estrogen treatment ...

Identifying the dangers of chronic stress on multiple sclerosis

February 6, 2018
New research reveals how chronic stress and tiny brain inflammations cause fatal gut failure in a multiple sclerosis mouse model.

Recommended for you

Broken shuttle may interfere with learning in major brain disorders

June 22, 2018
Unable to carry signals based on sights and sounds to the genes that record memories, a broken shuttle protein may hinder learning in patients with intellectual disability, schizophrenia, and autism.

Scientists discover fundamental rule of brain plasticity

June 21, 2018
Our brains are famously flexible, or "plastic," because neurons can do new things by forging new or stronger connections with other neurons. But if some connections strengthen, neuroscientists have reasoned, neurons must ...

Waking up is hard to do: Prefrontal cortex implicated in consciousness

June 21, 2018
Philosophers have pondered the nature of consciousness for thousands of years. In the 21st century, the debate over how the brain gives rise to our everyday experience continues to puzzle scientists. To help, researchers ...

Researchers find mechanism behind choosing alcohol over healthy rewards

June 21, 2018
A new study links molecular changes in the brain to behaviours that are central in addiction, such as choosing a drug over alternative rewards. The researchers have developed a method in which rats learn to get an alcohol ...

Scientists discover how brain signals travel to drive language performance

June 21, 2018
Effective verbal communication depends on one's ability to retrieve and select the appropriate words to convey an intended meaning. For many, this process is instinctive, but for someone who has suffered a stroke or another ...

Study on instinctive behaviour elucidates a synaptic mechanism for computing escape decisions

June 21, 2018
How does your brain decide what to do in a threatening situation? A new paper published in Nature describes a mechanism by which the brain classifies the level of a threat and decides when to escape.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.